Shares of Sarepta Therapeutics declined after it swung to a third-quarter loss and reported two of its therapies didn't meet statistical significance in a recent trial. The stock slid 36% to $15.67 in ...
The crypto market is having a bearish start to the new month as Bitcoin and other major cryptocurrencies fail to rally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback